Eurofarma is awarded at the 42nd edition of the Gold Lupa Award
Published in: October 26, 2018
and updated in: November 4, 2021
Listen to the text
Stop the audio
São Paulo, October 26, 2018 - Eurofarma, a Brazilian pharmaceutical company with 100% national capital, won important prizes during the 42nd edition of the Gold Lupa Award, a Sindusfarma event that honors the best companies and marketing campaigns in the pharmaceutical sector.
Eurofarma was a finalist in seven of the 22 categories of the award, and won the 1st place in the categories "Prescription - Mature Central Nervous System" with the Amato® product and "Prescription - Launch Central Nervous System" with the Desve® product. In addition, it won the 2nd place in the category "Prescription - Launch Central Nervous System" with the Cogmax® product.
The company has also won the 3rd place in the categories "Best Market Intelligence Project", "Prescription - Central Nervous System", "Prescription - Mature Other Classes", "Best Sales Force" and "Generic Corporate Performance”.
About Eurofarma Brazil
With 46 years of existence, the Eurofarma Group is the first Brazilian pharmaceutical multinational with 100% national capital, being recognized by the medical community and society for promoting access to health and quality of life with a fair price, quality and innovative treatments.
Present in 20 countries, it operates in the area of Prescription Medical and Non Prescription, Generics, Hospital, Biddings, Oncology, Veterinary and Services for segments of third parties. In Brazil, the portfolio is represented by 335 brands in 844 presentations, including 28 medical specialties and 148 therapeutic classes.
For more information, visit www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram:@eurofarma_br
Eurofarma
Stephanie Van Sebroeck +55 11 5090-8600 ext.8369 – stephanie@gaspar.com.br
Guilherme Gaspar +55 11 3065-3045 – guilherme@gaspar.com.br
Eurofarma was a finalist in seven of the 22 categories of the award, and won the 1st place in the categories "Prescription - Mature Central Nervous System" with the Amato® product and "Prescription - Launch Central Nervous System" with the Desve® product. In addition, it won the 2nd place in the category "Prescription - Launch Central Nervous System" with the Cogmax® product.
The company has also won the 3rd place in the categories "Best Market Intelligence Project", "Prescription - Central Nervous System", "Prescription - Mature Other Classes", "Best Sales Force" and "Generic Corporate Performance”.
About Eurofarma Brazil
With 46 years of existence, the Eurofarma Group is the first Brazilian pharmaceutical multinational with 100% national capital, being recognized by the medical community and society for promoting access to health and quality of life with a fair price, quality and innovative treatments.
Present in 20 countries, it operates in the area of Prescription Medical and Non Prescription, Generics, Hospital, Biddings, Oncology, Veterinary and Services for segments of third parties. In Brazil, the portfolio is represented by 335 brands in 844 presentations, including 28 medical specialties and 148 therapeutic classes.
For more information, visit www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram:@eurofarma_br
Eurofarma
Stephanie Van Sebroeck +55 11 5090-8600 ext.8369 – stephanie@gaspar.com.br
Guilherme Gaspar +55 11 3065-3045 – guilherme@gaspar.com.br